Product Information
RYNEX PE LIQUID is a generic product labeled by Edwards Pharmaceuticals, Inc., priced at $0.0466 per ML under NDC 00485020216. Its NADAC has been published 285 times since Apr 20, 2016.
Strength
1; 2.5 mg/5mL; mg/5mL
Manufacturer
Edwards Pharmaceuticals, Inc.NDC
00485020216
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/7/2011
Pharmacological Classes
Price Statistics
The NADAC for RYNEX PE LIQUID has been published 285 times since Apr 20, 2016, and over the history we have for it it has risen 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0466 per ML |
|---|---|
| All-time high | $0.0466 (Sep 30, 2026) |
| All-time low | $0.0316 (Apr 20, 2016) |
| 52-week high | $0.0466 |
| 52-week low | $0.0427 |
| Median price | $0.0335 |
| Average price | $0.0375 |
| Largest weekly change | +22.1% (Apr 17, 2024) |
| Weeks tracked | 285 |
| Tracking since | Apr 20, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BROMPHENIRAMINE MALEATE and Phenylephrine HCL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Edwards Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BROMPHENIRAMINE MALEATE and Phenylephrine HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RYNEX PE LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for RYNEX PE LIQUID, manufactured by Edwards Pharmaceuticals, Inc., is $0.0466 per ML (NDC 00485020216), effective Sep 30, 2026.
How has the price of RYNEX PE LIQUID changed over time?
Over the history we have for it, the NADAC for RYNEX PE LIQUID has risen 47.2%. It has been tracked across 285 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for RYNEX PE LIQUID?
Since Apr 20, 2016, the NADAC for RYNEX PE LIQUID has ranged from a low of $0.0316 (Apr 20, 2016) to a high of $0.0466 (Sep 30, 2026), with a median of $0.0335 per ML.
Are there cheaper alternatives to RYNEX PE LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of RYNEX PE LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RYNEX PE LIQUID?
RYNEX PE LIQUID (NDC 00485020216) is labeled by Edwards Pharmaceuticals, Inc., and CMS classifies it as a generic product.